Mathematical Modelling and Simulation, or Model Informed Drug Development (MIDD), is a powerful tool to support drug development, regulatory review and investment decisions. Modelling techniques, such as PK/PD, QSP and PopPK can be applied across the drug development continuum, integrating information from diverse data sources to gain deeper insights into drug mechanism of action, predict research outcomes and help inform research decision-making.